Order Article Reprints

Pijnappel EN, Wassenaar NPM, Gurney-Champion OJ, Klaassen R, van der Lee K, Pleunis-van Empel MCH, Richel DJ, Legdeur MC, Nederveen AJ, van Laarhoven HWM, et al. Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancers. 2021; 13(19):4869. https://doi.org/10.3390/cancers13194869

Pijnappel, Esther N., Nienke P. M. Wassenaar, Oliver J. Gurney-Champion, Remy Klaassen, Koen van der Lee, Marjolein C. H. Pleunis-van Empel, Dick J. Richel, Marie C. Legdeur, Aart J. Nederveen, Hanneke W. M. van Laarhoven, and et al. 2021. "Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer" Cancers 13, no. 19: 4869. https://doi.org/10.3390/cancers13194869

Pijnappel, E. N., Wassenaar, N. P. M., Gurney-Champion, O. J., Klaassen, R., van der Lee, K., Pleunis-van Empel, M. C. H., Richel, D. J., Legdeur, M. C., Nederveen, A. J., van Laarhoven, H. W. M., & Wilmink, J. W. (2021). Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Cancers, 13(19), 4869. https://doi.org/10.3390/cancers13194869